| Name | Title | Contact Details |
|---|
Special Needs Network, Inc. (SNN) is a nonprofit organization focused on supporting individuals with autism and other developmental disabilities, particularly in underserved communities. Founded in 2005 by Areva D. Martin, Esq., SNN aims to raise awareness about the intersection of disability rights and social justice, especially within the BIPOC community. SNN offers various services, including social skills training, respite care for caregivers, and parent training programs. The organization actively engages in initiatives to influence public policy and reduce barriers to resources for families. They work to empower families to advocate for themselves and provide unique learning opportunities to enhance the lives of those with developmental disabilities. Located in Los Angeles, SNN serves families and individuals throughout California, accepting multiple insurance carriers to facilitate access to their services. Their impactful projects include collaborations with local healthcare facilities to improve services for those with developmental disabilities.
Emersoncade Holding is a Denver, CO-based company in the Business Services sector.
Accelerate is a Scottsdale, AZ-based company in the Business Services sector.
Adlink enables advertisers to reach nearly 3.2 million cable households in the Los Angeles market through powerful television programming that spans across forty-four top rated networks including: ESPN, MTV, Lifetime, TNT, CNN, Comedy Central, A&E,
Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies (IRO`s). It forms the second largest site network in the world with more than 100 sites across 5 countries on 2 continents. Its unique ownership model combines the strengths of 11 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs. Its member companies have over 100 years of combined experience and completed more than 7,000 studies helping to evaluate thousands of new drugs and treatments in more than 140,000 patients.